The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Redx confirms Jounce deal lapses, Tirupati seals deal

Mon, 03rd Apr 2023 18:05

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Redx Pharma PLC - Macclesfield, England-based clinical-stage biotechnology company - Confirms that proposed all-share merger with Jounce Therapeutics has formally lapsed. Follows decision by Jounce to agree an alternative merger proposal with Concentra Biosciences, announced on March 27. Chief Executive Lisa Anson calls decision "disappointing," but notes Redx is "poised to achieve significant value inflection points from both clinical stage assets and development candidates in the next 12 months." Continues to evaluate relevant strategic and financial opportunities.

----------

Great Eastern Energy Corp Ltd - Asansol, India-based coal bed methane company - Confirms the last day of trading of the global depository receipts will be April 21. Following cancellation, GDRs will become unlisted GDRs. Apart from being unlisted, GDRs will continue to have the same structure as present.

----------

Litigation Capital Management Ltd - asset manager specialising in dispute financing solutions - Announces the realisation and cash receipt of an investment which forms part of LCM's Fund I portfolio. In December, High Court judged in favour LCM's funded party, the liquidator of CGL Realisations Ltd, formerly known as Comet Group Ltd. Under the judgement around GBP110 million was paid into court by the respondent who is appealing the ruling. In the interim, the liquidator procured a judgment protection insurance policy. Subsequently, an application was made for payment of sufficient monies to pay LCM's entitlements under the litigation funding agreement as well as the cost of defending the appeal. This enabled the liquidator to finalise its obligations to LCM, bringing about a conclusion to this investment. CEO Patrick Moloney says: "The resolution provides a further example of how the use of managed third party investment funds leverages the return to LCM's balance sheet and its equity investors."

----------

Kefi Gold and Copper PLC - Gold exploration and development company, focused on Ethiopia and Saudi Arabia - Reports maiden mineral resource estimate at the Al Godeyer Project, which forms part of the Hawiah Complex, part of Kefi's Saudi Arabian joint-venture Gold and Minerals Company Ltd. Says MRE of 1.4 million tonnes at 0.6% copper, 0.54% zinc, 1.4 grams per tonne of gold and 6.6 grams per tonne of silver potentially complements the inferred resources reported at the nearby Hawiah deposit of 11.1 million tonnes. This reaffirms the potential for an initial open-pit mining operation at Hawiah. Drilling planned to commence in the second quarter aimed at converting unclassified areas of the deposit to the Inferred category and to further test the strike extent of the orebody. Concurrent drilling planned at Hawiah will focus on upgrading and further expanding its total resources. Executive Chairman Harry Anagnostaras-Adams says: "Feedback from the early metallurgical test work is particularly exciting and demonstrates the amenability of Al Godeyer to provide additional open pit feed material to the proposed Hawiah Complex."

----------

Great Southern Copper PLC - copper-gold exploration company focused on Chile - Reports mapping identifies multiple mineralised vein-breccia structures at the Victoria prospect. Notes rock chip assay grades up to 6.9% copper and 1.85 grams per tonne of gold in the prospect. Sees potential for additional vein-breccia structures under shallow cover. Adds planning is now underway for the next phase of exploration at Victoria which is designed to identify targets for prospect-scale reconnaissance drilling. This work will include further detailed mapping and sampling complimented with trenching and magnetic and induced polarization geophysical surveys.

----------

San Leon Energy PLC - oil and gas production, development and exploration company focused on Nigeria - Updates on proposed transactions, refinancing and ELI operations. Reports longstop dates relation to proposed transactions with Midwestern Oil & Gas Co Ltd have been extended to June 30. This relates to the new Eroton debt facilities, the Sahara OML 18 acquisition agreement, the MLPL reorganisation agreement and the ELI reorganisation agreement. Continues to believe that the proposed transactions will be transformational.

----------

Tirupati Graphite PLC - London and Mumbai-based specialist graphite and graphene producer with operations in Madagascar and India - Completes acquisition of Suni Resources SA, the Mozambique incorporated subsidiary of ASX listed Battery Minerals Ltd. Deal was announced in September 2022.

----------

Provexis PLC - Reading, England-based producer of heart-health functional food ingredient Fruitflow - Updates on its capital structure and funding. Expects the group will need to raise further equity finance, or potentially new loan finance, in the coming months. Based on success of previous fund raising and the current performance of the business, continues to have a reasonable expectation of raising sufficient additional equity capital or new loan finance. Highlights renewed interest for Fruitflow. Committed to buy more than GBP550,000 of inventory from DSM. In direct contact with more than 50 actual and prospective Fruitflow customers and is seeking to ascertain the likely demand for the next 12 months and beyond, with particular regard to the best before dates of DSM's remaining inventory. In talks with DSM regarding extending initial inventory handover period. In talks with third party who may be able to hold inventory on a consignment basis.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
24 Feb 2016 09:44

Redx Pharma Makes Progress On Gonorrhoea Treatment And Other Drugs

Read more
20 Jan 2016 10:00

Redx Pharma Continues Pipeline Progressing In Maiden Results

Read more
13 Jan 2016 16:00

Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Jan 2016 08:35

New Redx director brings scientific, commercial expertise

(ShareCast News) - Redx announced the appointment of a non-executive director on Monday, with Dr Bernhard Kirschbaum joining the firm's board immediately. The AIM-listed self-described drug discovery and development company said Dr Kirschbaum was bringing with him more than 25 years experience in ph

Read more
3 Dec 2015 07:54

Redx Pharma Identifies New Cancer Drug Development Candidate

Read more
6 Nov 2015 09:42

DIRECTOR DEALINGS: Redx Pharma Chairman, Non-Executives Buy Shares

Read more
1 Oct 2015 07:36

Redx Pharma Says It Made "Good Progress" In Second Half

Read more
3 Sep 2015 08:00

Redx Pharma And Horizon Discovery Collaborating On Cancer Research

Read more
22 Jun 2015 14:17

Redx Pharma enjoys good progress during first-half

Two months after its admission to AIM, Redx Pharma said its first-half results were in line with expectations thanks to progress on potential MRSA drugs. Losses before tax rose 60.5% to £3.26m due to a decrease in grant funding and operating expenses increased 5% to £5.48m. The drug discovery and d

Read more
22 Jun 2015 08:35

Redx Pharma Positive For Full Year, Loss Widens In Maiden Interims

Read more
2 Jun 2015 11:13

Redx Pharma cheers with progress on potential MRSA drug

Redx shares jumped on the news it has reached the pre-clinical development stage with a new anti-infective compound designed to tackle MRSA, the bacteria that causes potentially lethal infections in humans. The pharmaceutical firm said the progress marked a "significant milestone" for its commercial

Read more
2 Jun 2015 07:00

Redx Pharma Progresses To Pre-Clinical Stage With MRSA Treatment

Read more
26 May 2015 07:43

Redx Pharma Identifies Second Drug Development Candidate

Read more
14 May 2015 09:41

Redx Pharma To Launch New Immunology Subsidiary

Read more
14 May 2015 08:55

Redx Pharma Says Third Paper On Antimicrobial Resistance Published

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.